Abstract:Phenylahistin is a naturally occurring marine product with a diketopiperazine structure that can bind to the colchicine site of microtubulin as a possible anticancer agent. To develop more potent microtubule inhibitors, novel phenylahistin derivatives were designed and synthesized based on the co-crystal complexes of phenylahistin derivatives and microtubulin. We established a focused library of imidazole-type molecules for the introduction of different groups to the C-ring and A-ring of phenylahistin. Structure-activity relationship studies indicated that appropriate hydrocarbon substituents and unsaturated alkenyl substituents at the 1-position of the imidazole group are important for improving the activity of such compounds. In addition, this study found that propylamine groups could maintain the activity of these compounds, as exemplified by compound 16d (IC50 = 5.38 nM, NCI-H460). Compound 15p (IC50 = 1.03 nM, NCI-H460) with an allyl group exhibited potent cytotoxic activity at the nanomolar level against human lung cancer cell lines. Immunofluorescence assay indicated that compound 15p could efficiently inhibited microtubule polymerization and induced a high expression of caspase-3. 15p also displayed good pharmacokinetic characteristics in vitro. Additionally, the growth of H22 transplanted tumors was significantly inhibited in BALB/c mice when 15p alone was administered at 4 mg/kg, and the tumor inhibition rate was as much as 65%. Importantly, the continuous administration of 15p resulted in a lower toxicity than that of docetaxel (10 mg/kg) and cyclophosphamide (20 mg/kg). Overall, the novel allyl-imidazole-diketopiperazine-type derivatives could be considered safe and effective potential agents for cancer treatment.

Design and Synthesis of Piperazine Acetate Podophyllotoxin Ester Derivatives Targeting Tubulin Depolymerization As New Anticancer Agents.

Synthesis and biological evaluation of cytotoxic activity of novel podophyllotoxin derivatives incorporating piperazinyl-cinnamic amide moieties

Synthesis and Evaluation of Novel Podophyllotoxin Derivatives As Potential Antitumor Agents.

Synthesis And Evaluation Of New Podophyllotoxin Derivatives With In Vitro Anticancer Activity

Design, Synthesis and Anti-Cancer Evaluation of Novel Podophyllotoxin Derivatives As Potent Tubulin-Targeting Agents

Design, Synthesis and Antitubulin Activity of Novel Podophyllotoxin Derivatives As Potent Anticancer Agent

Discovering Podophyllotoxin Derivatives As Potential Anti‐Tubulin Agents: Design, Synthesis and Biological Evaluation

Synthesis and Biological Evaluation of a Series of Podophyllotoxins Derivatives As a Class of Potent Antitubulin Agents.

Design and Synthesis of N-phosphoryl Peptide Modified Podophyllotoxin Derivatives As Potent Anticancer Agents.

Design, Synthesis, Biological Evaluation, and 3D-QSAR Analysis of Podophyllotoxin-Dioxazole Combination As Tubulin Targeting Anticancer Agents.

Novel Podophyllotoxin Derivatives as Potential Tubulin Inhibitors: Design, Synthesis and Anti-proliferative Activity Evaluation.

Discovery of Novel N-Heterocyclic-Fused Deoxypodophyllotoxin Analogues As Tubulin Polymerization Inhibitors Targeting the Colchicine-Binding Site for Cancer Treatment.

Biological evaluation and molecular modelling study of podophyllotoxin derivatives as potent inhibitors of tubulin polymerization.

Synthesis of novel aryl dithian valeryl podophyllotoxin ester derivatives as potential antitubulin agents

Design, Synthesis, Molecular Modeling, and Biological Evaluation of Pyrazole-Naphthalene Derivatives As Potential Anticancer Agents on MCF-7 Breast Cancer Cells by Inhibiting Tubulin Polymerization.

Design and synthesis of novel 4'-demethyl-4-deoxypodophyllotoxin derivatives as potential anticancer agents.

Design, Synthesis and Biological Evaluation of Novel 4-(4-Methoxynaphthalen-1-yl)-5-arylpyrimidin-2-amines as Tubulin Polymerization Inhibitors

Design, synthesis, and biological evaluation of novel diphenylamine derivatives as tubulin polymerization inhibitors targeting the colchicine binding site

Design, synthesis and biological evaluation of novel podophyllotoxin derivatives as tubulin-targeting anticancer agents

Design and synthesis of novel 3-amino-5-phenylpyrazole derivatives as tubulin polymerization inhibitors targeting the colchicine-binding site

Design and Synthesis of Novel Phenylahistin Derivatives Based on Co-Crystal Structures As Potent Microtubule Inhibitors for Anti-Cancer Therapy